Mach7 Technologies signs $0.5M Temple Health deal
Por Mahathir BayenaPontos principais
- Temple Health signed a 5-year subscription licence for Mach7’s eUnity Viewer and Vendor Neutral Archive software.
- The contract is expected to add $0.5 million in Year 1 annual revenue, while Mach7 shares held steady at $0.26.
- The agreement expands Mach7’s footprint among U.S. academic health systems as it focuses on growing recurring software revenue.
Mach7 Technologies (ASX:M7T) signed a 5-year software subscription contract with Philadelphia-based Temple Health, expecting $0.5 million in first-year recurring revenue.
The deal follows Mach7’s FY26 full-year revenue decline of 17.4% to $27.9 million and supports its FY27 focus on recurring revenue growth.
"We are delighted to partner with Temple Health to help its clinicians access the imaging information they need across their hospitals and speciality centres,” said Mach7 CEO and Managing Director Teri Thomas.
The contract took effect on Oct. 30, with Mach7 stating that first productive use is expected within 6 to 12 months.
Temple Health operates 990 licensed beds across multiple campuses, and Mach7 stated the partnership strengthens its presence in academic health systems.
Following the announcement, the Mach7 share price was unchanged at $0.26.
Mach7 provides enterprise medical imaging software and recently reported four consecutive quarters of positive operating cash flow, ended September with $19.3 million in cash and no debt.
Over the past several months, Mach7 appointed Shawni Hadfield as chief financial officer, launched its Flamingo platform with UnityPoint Health, signed a 5-year $1.7 million deal with American Radiologist Network, and secured a 5-year $2.8 million expansion licence.
